Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Treatment and prophylaxis for Pneumocystis carinii pneumonia
W. T. Hughes
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment and prophylaxis for Pneumocystis carinii pneumonia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Agriculture & Biology
Pneumocystis carinii
100%
pneumonia
73%
disease control
59%
dapsone
53%
immunocompromised population
50%
chemoprevention
47%
combination drug therapy
47%
drugs
45%
sulfamethoxazole
41%
trimethoprim
39%
adverse effects
27%
toxicity
23%
methodology
9%
Medicine & Life Sciences
Trimetrexate
57%
Pneumonia
54%
Eflornithine
48%
Pentamidine
48%
pyrimethamine drug combination fanasil
47%
Pneumocystis carinii
44%
Dapsone
44%
Sulfamethoxazole Drug Combination Trimethoprim
37%
Chemoprevention
37%
Immunocompromised Host
36%
Drug Combinations
35%
Pharmaceutical Preparations
28%
Therapeutics
11%